Learn to Customize Your Own Options Trading Strategy
This guide will help you evaluate and analyze your trading plan to create a custom options trading strategy tailored to your risk profile and market outlook. Learn how to take your trading to the next level.
Download your FREE Options Strategy Guide Today!
Ilan Daskal, insider at Bio-Rad Laboratories
Ilan Daskal Insider Alerts

Get notified the next time Ilan Daskal buys or sells Bio-Rad Laboratories stock. Enter your email address below to get our daily insider buying and selling report.

Ilan Daskal Insider Information

Ilan Daskal was appointed Executive Vice President and Chief Financial Officer, effective April 6, 2019. Prior to joining Bio-Rad, Mr. Daskal, was the Chief Financial Officer of Lumileds, a global leader in advanced lighting technology, from May 2017 to January 2019. From 2015 through 2016, Mr. Daskal held multiple short-term Chief Financial Officer roles with private and public companies including Aricent Inc., a global design and engineering company, Cepheid, a molecular diagnostic company, and SunEdison Inc., a renewable energy company. Prior to that, from 2008 to 2015, Mr. Daskal was the Executive Vice President and Chief Financial Officer at International Rectifier Corporation, a leader in power management semi-conductor technology that was publicly traded until it was acquired by Infineon Technologies in 2015. Mr. Daskal also currently serves on the Board of Directors of Natus Medical Incorporated, a publicly-traded provider of medical device solutions.

What is Ilan Daskal's net worth?

The estimated net worth of Ilan Daskal is at least $6,672.42 as of September 3rd, 2021. Mr. Daskal owns 9 shares of Bio-Rad Laboratories stock worth more than $6,672 as of December 5th. This net worth approximation does not reflect any other investments that Mr. Daskal may own. Learn More.

How do I contact Ilan Daskal?

The corporate mailing address for Mr. Daskal and other Bio-Rad Laboratories executives is 1000 ALFRED NOBEL DRIVE, HERCULES CA, 94547. Bio-Rad Laboratories can also be reached via phone at (510) 724-7000 and via email at [email protected]

Has Ilan Daskal been buying or selling shares of Bio-Rad Laboratories?

Ilan Daskal has not been actively trading shares of Bio-Rad Laboratories during the past quarter. Most recently, Ilan Daskal sold 270 shares of the business's stock in a transaction on Friday, September 3rd. The shares were sold at an average price of $820.06, for a transaction totalling $221,416.20. Following the completion of the sale, the chief financial officer now directly owns 9 shares of the company's stock, valued at $7,380.54.

Who are Bio-Rad Laboratories' active insiders?

Bio-Rad Laboratories' insider roster includes Michael Crowley (EVP), Ilan Daskal (CFO), Timothy Ernst (EVP), and Annette Tumolo (EVP).

Are insiders buying or selling shares of Bio-Rad Laboratories?

In the last twelve months, insiders at the medical research company sold shares 7 times. They sold a total of 8,417 shares worth more than $6,314,715.80. The most recent insider tranaction occured on November, 11th when EVP Annette Tumolo sold 1,546 shares worth more than $1,157,954.00. Insiders at Bio-Rad Laboratories own 27.7 % of the company.

Information on this page was last updated on 11/11/2021.

Ilan Daskal Insider Trading History at Bio-Rad Laboratories

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
9/3/2021Sell270$820.06$221,416.209View SEC Filing Icon  
8/4/2021Sell2,300$751.84$1,729,232.00View SEC Filing Icon  
See Full Table

Ilan Daskal Buying and Selling Activity at Bio-Rad Laboratories

This chart shows Ilan Daskal's buying and selling at Bio-Rad Laboratories by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Bio-Rad Laboratories Company Overview

Bio-Rad Laboratories logo
Bio-Rad Laboratories, Inc. engages in the development and production of specialty chemicals used in biochemical, pharmaceutical, and other life science research applications. It operates through the Life Sciences and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets reagents, apparatus, and laboratory instruments. The Clinical Diagnostics segment designs, manufactures, sells, and supports test systems, informatics systems, and test kits. The company was founded by David S. Schwartz and Alice N. Schwartz in 1952 and is headquartered in Hercules, CA.
Read More

Today's Range

Now: $741.38
Low: $733.37
High: $756.84

50 Day Range

MA: $749.20
Low: $708.84
High: $794.68

2 Week Range

Now: $741.38
Low: $537.12
High: $832.70

Volume

95,523 shs

Average Volume

102,220 shs

Market Capitalization

$22.18 billion

P/E Ratio

3.36

Dividend Yield

N/A

Beta

0.88
Learn to Customize Your Own Options Trading Strategy
This guide will help you evaluate and analyze your trading plan to create a custom options trading strategy tailored to your risk profile and market outlook. Learn how to take your trading to the next level.
Download your FREE Options Strategy Guide Today!